Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.33 -0.11 (-0.54%)
As of: Oct 21, 2026 · 11:41 AM EDT

Acadia Pharmaceuticals (ACAD) Non-Current Assets (2010 - 2026)

Updated

Acadia Pharmaceuticals (ACAD) recorded Non-Current Assets of $518.36 million in Q2 2026, up 95.6% from $265 million a year earlier and up 1.8% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Non-Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Acadia Pharmaceuticals reported Non-Current Assets of $502.08 million, up 101.3% from FY2024.

  • Annual Non-Current Assets has increased for three straight years, with a five-year compound annual growth rate of 50.5% (FY2020 to FY2025).
  • Across earlier years, Non-Current Assets came in at $249.44 million in FY2024 (+87.8%), $132.83 million in FY2023 (+66.3%), $79.88 million in FY2022 (-2.9%) and $82.3 million in FY2021 (+26.6%).
  • The Q2 2026 figure is the highest quarterly Non-Current Assets in data going back to Q4 2010.
  • On a year-over-year basis, Non-Current Assets has increased for 14 consecutive quarters, with growth averaging 68.0% over the last eight quarters.
  • Peak year-over-year performance for Non-Current Assets in the last five years was growth of 101.3% in Q4 2025, against a decline of 2.9% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $509.21 million (Q1 2026), $502.08 million (Q4 2025) and $254.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 141.29 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 101.45 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 87.87 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 35.42 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 159.77 Bn
10 Acadia Pharmaceuticals 3.49 Bn 19.20 Mn 279.64 Mn 518.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 518.36 Mn
Mar 31, 2026 509.21 Mn
Dec 31, 2025 502.08 Mn
Sep 30, 2025 254.35 Mn
Jun 30, 2025 265.00 Mn
Mar 31, 2025 261.42 Mn
Dec 31, 2024 249.44 Mn
Sep 30, 2024 188.58 Mn
Jun 30, 2024 185.18 Mn
Mar 31, 2024 179.81 Mn
Dec 31, 2023 132.83 Mn
Sep 30, 2023 133.37 Mn
Jun 30, 2023 150.14 Mn
Mar 31, 2023 152.46 Mn
Dec 31, 2022 79.88 Mn
Sep 30, 2022 80.94 Mn
Jun 30, 2022 80.25 Mn
Mar 31, 2022 82.03 Mn
Dec 31, 2021 82.30 Mn
Sep 30, 2021 76.76 Mn
API Access

Acadia Pharmaceuticals Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=ACAD&period=max&api_key=YOUR_API_KEY